Paperpal Prime Logo

Drug Resistance Updates : Impact Factor & More

eISSN: 1532-2084pISSN: 1368-7646

Key Metrics

CiteScore
30.8
Eigenfactor
0.001 - 0.005
H-Index
125
Impact Factor
20 - 25
SJR
Q1Oncology
SNIP
3.67
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Drug Resistance Updates

Drug Resistance Updates Journal Specifications

Overview
Publisher CHURCHILL LIVINGSTONE
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1998
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Drug Resistance Updates ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Drug Resistance Updates

Lactate-driven H3K18 lactylation promotes cisplatin resistance in bladder cancer via HNRNPF-Parkin mediated mitophagy.
  • 1 Sep 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Biomimetic delivery systems for overcoming drug resistance in gastrointestinal cancers.
  • 6 Aug 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
ITPKB suppresses ER calcium release to promote CXCL9 expression and enhance immunotherapy sensitivity in triple-negative breast cancer.
  • 2 Aug 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Targeting a novel metabolic vulnerability of non-small cell lung cancer to fatty acid oxidation surmounts chemoresistance.
  • 2 Aug 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
MZF1-mediated GAPDH overexpression drives glycolytic reprogramming and neuroendocrine progression in advanced prostate cancer.
  • 1 Aug 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Protein SUMOylation confers sorafenib resistance in human hepatocellular carcinoma via the induction of PKM2-mediated glycolysis.
  • 16 Jul 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Lactate-driven H3K18 lactylation promotes cisplatin resistance in bladder cancer via HNRNPF-Parkin mediated mitophagy.
  • 1 Sep 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Biomimetic delivery systems for overcoming drug resistance in gastrointestinal cancers.
  • 6 Aug 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
ITPKB suppresses ER calcium release to promote CXCL9 expression and enhance immunotherapy sensitivity in triple-negative breast cancer.
  • 2 Aug 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Targeting a novel metabolic vulnerability of non-small cell lung cancer to fatty acid oxidation surmounts chemoresistance.
  • 2 Aug 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
MZF1-mediated GAPDH overexpression drives glycolytic reprogramming and neuroendocrine progression in advanced prostate cancer.
  • 1 Aug 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Protein SUMOylation confers sorafenib resistance in human hepatocellular carcinoma via the induction of PKM2-mediated glycolysis.
  • 16 Jul 2026
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

FAQs on Drug Resistance Updates